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tional tracheostomy was performed to gain long-term
airway access. In patients who had undergone previous
median sternotomy, thoracic surgeons were concerned
about cross-contamination of the tracheostomy and
sternotomy wounds. The assumption was that the close
proximity of sternal wound and tracheostomy leads to
contamination of the sternotomy with bacteria from the
airways, resulting in sternal infections or mediastinitis.
Brown and coworkers1 demonstrated a significant rela-
tionship between tracheostomy and sternal wound
dehiscence or infection and therefore recommended
avoidance of tracheostomy at least until the tissue
planes had healed. In contrast, Marshall2 reported on
140 patients who had conventional tracheostomy after
heart operations without a single case of sternal wound
infection. However, the discussion of whether tra-
cheostomy should be performed before the median ster-
notomy had healed remained controversial. Pierce and
E lective tracheostomy of patients requiring long-termassisted ventilation is an established treatment
modality in intensive care medicine. In the era before
the introduction of percutaneous techniques, conven-
Objective: Tracheostomy offers significant advantages over endotracheal
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patients who have undergone median sternotomy, it is believed that the dan-
ger of microbial contamination and consecutive infection of the sternal
wound with microbes from the tracheostomy is high when conventional tra-
cheostomy is performed. In contrast, percutaneous techniques are less likely
to result in tracheostomy infection and thus bacterial contamination of
neighboring structures. Nonetheless, to date there has been no prospective
study confirming or disproving this assumption. Our study evaluated out-
come after percutaneous tracheostomy in patients with a median sternotomy.
Methods: A total of 144 cardiac surgical patients had elective percutaneous
tracheostomy at the bedside until postoperative day 14, with 4 different tech-
niques. Systematic microbiologic monitoring of the sternal and tracheal
wounds was used.
Results: In 13 patients sternal wound infection was suspected, but was con-
firmed in only 4 (2.8%) patients who actually showed microbial contamina-
tion of the sternum. In 2 of these patients, the identified microbes were not
identical to those cultured from the trachea. The other 2 patients had sternal
and tracheal cultures positive for methicillin-resistant Staphylococcus
aureus. Cross-contamination of the sternotomy with microbes from the
patient’s airways was therefore ruled out. No patient had clinical signs of tra-
cheostomy infection. Likewise, there were no cases of mediastinitis.
Conclusions: On the basis of our data, we conclude that cross-contamination
of the sternal wound with microbes from the trachea is not a problem.
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coworkers3 recommended performance of cricothyroid
tracheostomy to effectively isolate the tracheostomy
from the sternotomy and to seal the sternal wound until
postoperative day 14. In the 1990s, Hübner and
coworkers4 presumed that the risk of postoperative
mediastinitis in most departments still leads to a hesi-
tant indication for tracheostomy within the first 2 post-
operative weeks.
Regardless of the fact that the pros and cons of tra-
cheostomy after median sternotomy are still being dis-
cussed, to date there are no studies with a large number of
patients and appropriate microbiologic testing proving the
hypothesis that early tracheostomy results in an increased
risk of sternal wound infections or mediastinitis.
Our study sought to determine whether percutaneous
tracheostomy within the first 14 days after median ster-
notomy can be considered safe and free from postoper-
ative infectious complications. Therefore, a total of 144
patients receiving tracheostomies with microbiologic
testing, using 4 different percutaneous tracheostomy
techniques, were studied.
Patients and methods
During a 41-month period, a total of 144 consecutive
patients who had undergone median sternotomy because of
cardiac operations at our institution and who received elective
percutaneous tracheostomy within the first 14 postoperative
days were included in the study after informed consent was
obtained from their relatives. Tracheostomies were performed
when the patients were not expected to be extubated within
the following 10 days.
All tracheostomies were performed after achievement of
general intravenous anesthesia by the same team at the
patient’s bedside in the intensive care unit (ICU) by means of
pressure-controlled ventilation. The inspired oxygen fraction
was set to 1.0 ten minutes before the procedure was started.
Intraoperative monitoring consisted of continuous electrocar-
diography, an indwelling arterial line, and pulse oximetry. In
every instance tracheostomy was done under fiberbroncho-
scopic control, either according to Ciaglia’s (percutaneous
dilatational tracheostomy [PDT], n = 42, or Ciaglia blue
rhino [CBR], n = 12), Griggs’ (guide wire dilating forceps
[GWDF], n = 34), or Fantoni’s (translaryngeal tracheostomy
[TLT], n = 56) techniques, all of which have been described
elsewhere.5-8 The choice of procedure was made by the sur-
geon, depending on a number of individual factors, such as
the degree of respiratory insufficiency or coagulopathy. Strict
contraindications for percutaneous tracheostomy were diffi-
cult cervical anatomy with unidentifiable anatomic land-
marks, known or expected difficult endotracheal intubation,
and visible large blood vessels in the operative field. If con-
traindications applied, these patients were scheduled to
undergo conventional surgical tracheostomy. Finally, all
patients underwent bronchoscopy after completion of percu-
taneous tracheostomy to suction blood or saliva from the tra-
chea if necessary.
On the morning before tracheostomy, as well as 2 days after
the procedure, tracheal secretions were obtained and cultured
for bacteria and fungi. Cultures from the sternotomy wound
were obtained only if there were clinical signs of infection of
the wound, which was checked at least once every day.
Likewise, the tracheostomy wound was inspected daily, and
cultures were obtained only when infection was suspected.
All tracheal cultures underwent complete microbiologic
analysis. Likewise, all cultures from the sternotomy wound
obtained on every second day within a week before and a
week after tracheostomy were compared with the tracheal
cultures of the individual patients. In this way we sought to
detect cross-contamination of the sternal and tracheal
wounds.
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Table I. Surgical interventions and indications for elective tracheostomy in patients who underwent median 
sternotomy
TLT PDT GWDF CBR Total
(n = 56) (n = 42) (n = 34) (n = 12) (n = 144)
Interventions
Coronary artery bypass grafting 31 29 27 7 94
Coronary artery bypass grafting and valve repair or replacement* 13 5 0 1 19
Valve repair or replacement 5 2 5 2 14
Other 7 6 2 2 17
Indications for tracheostomy
Respiratory insufficiency 17 15 10 8 50
Sepsis 11 12 6 1 30
Low cardiac output 11 9 7 2 29
Severe illness polyneuropathy† 1 0 4 0 5
Multiorgan failure 3 1 2 0 6
Cerebral disorders 13 5 5 1 24
TLT, Translaryngeal tracheostomy; PDT, percutaneous dilatational tracheostomy; GWDF, guide wire dilating forceps; CBR, Ciaglia blue rhino. 
*P = .04.
†P = .02.
Once the homogeneity of the data was confirmed, 1-way
analysis of variance was used to compare the raw data in
terms of means and SD, whereas the Fisher exact test and the
χ2 test for independence were used to compare contingencies.
All statistical calculations were performed by means of
GraphPad InStat Version 3.00 software (GraphPad Software,
Inc, San Diego, Calif).
Results
A total of 144 cardiac surgical patients (76 male and
68 female patients) with a median sternotomy who
were in the ICU received elective percutaneous tra-
cheostomy up to postoperative day 14 because of the
need for long-term assisted ventilation. Until tra-
cheostomy, all patients had either oral or nasal endotra-
cheal tubes. All tracheostomies were performed at the
patient’s bedside in the ICU. The TLT (n = 56), PDT (n
= 42), GWDF (n = 34), and CBR (n = 12) tracheosto-
my techniques were used. Types of cardiac procedures
and indications for long-term ventilation and thus tra-
cheostomy are listed in Table I.
Tracheostomy was performed on day 9 (median
value) after median sternotomy. With regard to the dif-
ferent techniques, tracheostomy timing was similar (P
> .2). Fig 1 shows the number of the various technical
procedures, as well as the day of tracheostomy. Forty
(27.8%) of the patients had tracheostomies within the
first week after median sternotomy, whereas 104
(72.2%) received percutaneous tracheostomy within
the second postoperative week. No patient underwent
open tracheostomy because of contraindications for
percutaneous techniques.
In 103 (before tracheostomy) and 92 patients (after
tracheostomy), tracheal cultures were positive for bac-
teria, fungi, or both. Between the different patient
groups, there were no statistically significant differ-
ences with regard to the number of positive tracheal
cultures both before and after tracheostomy (P > .2).
Likewise, preoperative and postoperative prevalence
for positive cultures was similar within a given group
(P > .2). Bacteria that were detected were either
apathogenic and thus did not require antibiotic treat-
ment or received adequate antibiotic coverage in case
of pathogenicity (Table II).
A total of 13 (9.0%) patients showed clinical signs
of an infected sternal wound within the first week
before and after tracheostomy. Two of these patients
had received tracheostomy according to the Fantoni
technique (TLT) while they still had an open thorax.
In 4 (2.8%) patients sternal cultures were positive for
bacteria or fungi, which was considered proof of
infection. In 1 patient, sternal culture on the first day
after TLT was positive for Enterococcus faecalis,
whereas the tracheal culture showed Acinetobacter
species. The postoperative tracheal cultures had been
negative. In the PDT group there was also a positive
sternal culture, namely, Candida albicans. However,
both tracheal cultures were negative for bacteria and
fungi. Two patients from the GWDF group showed
contamination of the sternotomy wound with methi-
cillin-resistant Staphylococcus aureus both before
and after tracheostomy. Methicillin-resistant S aureus
was also found in both tracheal cultures of these
patients.
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Fig 1. Time period between median sternotomy and percutaneous tracheostomy in 144 patients who underwent car-
diac surgery. CBR, Ciaglia blue rhino; GWDF, guide wire dilating forceps; PDT, percutaneous dilatational tra-
cheostomy; TLT, translaryngeal tracheostomy.
In 9 of the patients with clinical signs of sternal
wound infection, including 2 patients with an open tho-
rax, sternal cultures tested negative. Therefore, sternal
wound infection was ruled out. Nonetheless, all of
these patients had positive tracheal cultures with bacte-
ria, such as Haemophilus influenzae, Pseudomonas
aeruginosa, or Klebsiella pneumoniae. Regardless of
the technique chosen for tracheostomy, no patient
showed clinical signs of infection of the tracheostomy
wound. Likewise, there was no case of mediastinitis.
The risk of complications during tracheostomy was
low. In 4 patients complications occurred that required
instant intervention, namely, major bleeding in 2
patients who had either PDT or GWDF. In 1 patient of
the TLT group, pretracheal insertion of the tracheosto-
my tube was detected bronchoscopically. After rapid
reintubation, uneventful PDT was performed. Further-
more, mediastinal emphysema occurred a few hours
after uneventful GWDF but resolved spontaneously
within the next 72 hours. All complications could be
managed without difficulties by the team that had per-
formed the tracheostomy.
Discussion
Tracheostomy is one of the oldest procedures in the
history of surgery and is often indicated when there is
a need for prolonged mechanical ventilation. In com-
parison with oral or nasal endotracheal intubation, tra-
cheostomy facilitates airway toilet and weaning from
the ventilator. Enteral feeding can be restarted earlier,
and the procedure is well tolerated by the patients and
accepted by the nursing staff.9,10 However, the contro-
versy with regard to the optimal timing of tracheosto-
my is still unresolved. In 1989, the Consensus
Conference on Artificial Airways recommended that
elective tracheostomy be performed early between days
3 and 5 if weaning from the respirator could not be
foreseen within the next 21 days. If the period of
expected intubation could not be determined, the pros
and cons of tracheostomy should be evaluated on a
daily basis.11 Several studies have shown that the criti-
cal period for the development of laryngotracheal
lesions caused by the endotracheal tube is between the
seventh and eleventh days of intubation and maybe ear-
lier.12-14 As a consequence, many authors recommend
that an elective tracheostomy be performed after about
day 10 of intubation.15-17
Before percutaneous tracheostomy became popular
with the introduction of PDT in 1985,5 conventional
tracheostomy was performed for long-term airway
control. A number of studies demonstrated that severe
tracheostomy wound infection, defined as peristomal
cellulitis, skin necrosis, skin breakdown or purulent
secretions at the stoma, or peristomal infection that
necessitates antibiotic coverage, is a frequent compli-
cation of the conventional technique and occurs in
17% to 36% of patients.16,18-20 Particularly in proxim-
ity to a sternotomy wound, purulent secretions are a
cause for concern. A significant relationship between
conventional tracheostomy and major sternal wound
dehiscence or infection has been reported by Brown
and coworkers,1 who reviewed the case histories of
748 patients who had cardiac operations. By way of
minimizing the risk of sternal wound contamination
from the tracheostomy, sophisticated sternal wound
dressings were developed, presumably eliminating or
reducing the risk of wound infection and mediastini-
tis in patients who underwent either tracheostomy
before the sternotomy had healed or sternotomy while
having a pre-existing tracheostomy.3,21,22 Severe tra-
cheostomy infections have been significantly less fre-
quent with percutaneous tracheostomy than with con-
ventional tracheostomy,4,15,16,19,20,23-25 and only one
study demonstrated that no wound infections occurred
regardless of whether percutaneous or conventional
tracheostomy was performed.17 The question of
whether percutaneous tracheostomy can be performed
early after median sternotomy without exposing the
patients to the risks of sternal wound infection or
mediastinitis has not been answered to date by means
of a study in a large number of patients and appropri-
ate microbiologic testing.
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Table II.  Results of microbiologic cultures from tracheal secretions of patients who had percutaneous tracheosto-
my after median sternotomy
TLT (n = 56) PDT (n = 42) GWDF (n = 34) CBR (n = 12) Total (n = 144)
Before After Before After Before After Before After Before After
Patients with negative results 18 18 13 19 6 8 4 7 41 52
Patients with positive results 38 38 29 23 28 26 8 5 103 92
TLT, translaryngeal tracheostomy; PDT, percutaneous dilatational tracheostomy; GWDF, guide wire dilating forceps; CBR, Ciaglia blue rhino. 
The era of minimally invasive tracheostomy started
in 1985 with the description and introduction of
Ciaglia’s PDT.5 PDT became the most established
technique, but the percutaneous techniques of Griggs
(GWDF) and Fantoni (TLT) were shown to be equally
safe and practicable.6,7,23-25 Because the percutaneous
tracheostomy techniques are cost-efficient, easily per-
formed at the patient’s bedside, and safe and virtually
free of major complications, they are increasingly
being used instead of surgical tracheostomy and have
been established as a modern treatment modality in
intensive care medicine.26 In our study only 4 (2.8%) of
144 patients had perioperative complications, all of
which were readily managed by the tracheostomy team
and posed no major threat to the patients. A key ele-
ment of percutaneous techniques is the fact that the tra-
cheal cannula is positioned by dilation only. As a result,
there is an extremely tight fit of the tracheal cannula
because the elastic wound edges firmly adhere to the
cannula. In consequence, contact of the tracheostomy
with tracheal secretion is minimized, and infections are
thus unlikely. Similarly, contamination of the cervical
and thoracic regions with tracheal secretions is virtual-
ly impossible. This is very different in the case of con-
ventional surgical tracheostomy, in which microbial
contamination of both the tracheostomy itself and of
the cervical and thoracic regions, including the sternal
wound and mediastinum, seems much more likely.
To date, there is only one study of 45 patients who
had early elective percutaneous tracheostomy accord-
ing to Griggs’ GWDF technique after a median ster-
notomy. Tracheostomy was performed on postopera-
tive day 6 (median) and sometimes as early as on the
second day after median sternotomy. There was not a
single case of infection of the sternal wound. However,
the study was based on clinical findings exclusively.4 In
comparison with our investigation, there was no micro-
bial testing of both the tracheal secretions and the ster-
nal wound. However, we also obtained sternal cultures
only when daily inspection revealed clinical signs of
wound infection, such as erythema or purulent secre-
tion, either alone or in combination with fever, elevat-
ed white blood cell count, or elevated C-reactive pro-
tein. We could show that, at the time of tracheostomy,
71.5% of our patients had tracheal cultures positive for
microbes, some of which were highly pathogenic and
likely to cause sternal wound infections. Regardless of
a high prevalence of airway contamination with
microbes, sternotomy infection was suspected in only
13 (9.0%) patients on the basis of clinical findings, and
pathogenic microbes that actually confirmed wound
infection were found in the sternal swabs of only 4
(2.8%) patients. In 2 of these patients, we were able to
demonstrate that the types of microbes from the sternal
wound were not identical with the ones from the air-
ways. Hence, cross-contamination could be ruled out.
Although in the 2 other patients methicillin-resistant S
aureus was cultured from both the sternal wound and
the tracheal secretions, both patients had positive test
results for methicillin-resistant S aureus before tra-
cheostomy. Again, cross-contamination could be
excluded. In the remaining 9 patients whose sternal
cultures tested negative and therefore could have ster-
nal wound infection ruled out, pathogenic microbes
were found in their airways. Furthermore, 2 patients
who underwent tracheostomy according to the Fantoni
technique while having an open thorax had sternal cul-
tures negative for both bacteria and fungi. It bears
emphasis that not a single patient had clinical signs of
tracheostomy infection at daily inspection.
Our results demonstrate clearly that percutaneous
tracheostomy regardless of the technique is safe, even
if performed during the first 2 weeks after median ster-
notomy. There was no contamination of the sternal or
mediastinal regions with microbes from the airways. In
addition, the incidence of perioperative complications
was only 2.8%. Thus, percutaneous techniques are safe
with regard to microbiologic considerations. For all
these reasons, we strongly believe that cardiac surgical
patients on long-term mechanical ventilation should no
longer be denied the benefits of early percutaneous tra-
cheostomy.
We thank Hanns Ackermann, PhD, for statistical advice
and review.
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